preclinical biomarkers

Cilcare’s comprehensive in vivo biomarker studies are tailored to deliver precise insight into the dynamics of biological processes within living organisms. Leveraging cutting-edge technologies and rigorous methodology, we offer a wide range of services designed to facilitate advanced research and development. Whether you’re exploring therapeutic interventions, investigating disease mechanisms, or seeking to optimize treatment strategies, our expertise in in vivo biomarker analysis provides invaluable support:

• Plasma-based: assessing liver and kidney toxicity by evaluating associated enzymes, signs of inflammation (complete blood count and C-reactive protein), metabolic indicators (glucose levels, glycated hemoglobin), and more.
• Transcriptomics: analyzing transcriptome expression (RNA sequencing) or specific gene expression (mRNA by q-RT PCR) in fluids or tissues.
• Proteomics: assessing protein expression in fluids or tissues using ELISA or multiplex methods (e.g., for inflammation).